首页>
外国专利>
THERAPEUTIC FACILITIES AIMED AT THE CORN ENDOTHELY ECM
THERAPEUTIC FACILITIES AIMED AT THE CORN ENDOTHELY ECM
展开▼
机译:最终在ECM上实现了理疗设施
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides medicaments for treating or preventing a disease, disorder, or condition associated with extracellular matrix (ECM) abnormality in a corneal endothelium, wherein the medicaments comprise a TGF-beta signal inhibiting agent. More specifically, this disease, disorder, or condition is a disorder associated with Fuchs' endothelial corneal dystrophy. Such a disorder includes photophobia, blurred vision, vision disorder, eye pain, lacrimation, hyperemia, pain, bullous keratopathy, ophthalmic unpleasantness, a decrease in contrast, glare, edema in corneal stroma, bullous keratopathy, corneal opacity, and the like. A preferable TGF-beta signal inhibiting agent includes 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide.
展开▼